- Press releasesPress releases
- Events & ActivityEvents & Activity
- Dicerna Expands Lead GalXC™ Development Program to Encompass All Forms of Primary Hyperoxaluria (PH) and Reveals New Therapeutic Target for DCR-PHXC
- Dicerna Pharmaceuticals, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Dicerna Announces Appointment of Ralf Rosskamp, M.D., as Chief Medical Officer
- Dicerna to Present at Jefferies 2017 Global Healthcare Conference
- Dicerna Reports First Quarter 2017 Financial and Operational Results and Provides Corporate Update
- Dicerna to Report First Quarter 2017 Financial Results and Host Conference Call on May 8, 2017
Dicerna Pharmaceuticals Inc (DRNA:NSQ) closed at 4.13, 70.59% above the 52 week low of 2.42 set on Feb 03, 2017.
2.42Feb 03 20176.10Sep 30 2016
Markit short selling activity
|Market cap||85.88m USD|
|EPS (TTM)||-2.80 |
Data delayed at least 15 minutes, as of Jul 21 2017 21:00 BST.